| abstract |
[Problem] To provide a novel drug for improving metabolic syndrome. A compound represented by the general formula (I), which is a compound having 11β-HSD1 inhibitory activity, wherein R represents —CH 2 CH 2 OH, —CH (CO 2 H) CH 2 CH 2 CO 2 H, —H, Alternatively, a compound represented by —CH 2 COOH] or a salt thereof, and a method for producing the compound are provided. [Selection figure] None |